Plain-English translation of NCT07192965 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer type of heart imaging scan called ECG-less coronary CT angiography (CCTA) in people who come to the emergency room with chest pain and signs that their heart may be damaged. The study wants to see if this scan can accurately identify what's causing the chest pain—including dangerous conditions like blood clots in the lungs or tears in the heart's main artery—without requiring invasive procedures like cardiac catheterization (a tube inserted into blood vessels).
When people arrive at the emergency room with chest pain and elevated heart damage markers, doctors currently need to perform invasive procedures to diagnose the problem. This trial exists to see whether a less invasive scan could provide the same diagnostic information, reducing patient risk, procedure time, and radiation exposure while still keeping patients safe.
You likely qualify if…
You likely don't qualify if…
You would receive the newer heart scan (ECG-less CCTA) at the hospital, which takes images of your heart and its blood vessels using a single dose of contrast dye. After that scan, you would then undergo the standard invasive heart procedure (cardiac catheterization) as part of your regular care, so doctors can compare how well the two tests match up. The study involves this one visit to the emergency room where you receive both tests.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Belgium